플라보노이드 luteolin이 세포자멸사 관련 단백질 활성 억제를 통해 6-hydroxydopamine 세포독성에 미치는 억제효과

키워드

참고문헌 (39)

1. Olanow CW, "Etiology and pathogenesis of Parkinson's disease", Annu Rev Neurosci, 22, pp.123~144 (1999)
2. Jenner P., "Oxidative stress in Parkinson’s disease", Ann Neurol, 53, pp.26~38 (2003)
3. Bernstein AI, "6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death", Mol Neurodegener, 6, pp.2~ (2011)
4. Blandini F, "The 6-hydroxydopamine model: news from the past", Parkinsonism Relat Disord, 14, pp.124~129 (2008)
5. BovéJ, "Toxin-induced models of Parkinson’s disease", NeuroRx, 2, pp.484~494 (2005)
6. Lee CS, "Differential effect of catecholamines and MPP+ on membrane permeability in brain mitochondria and cell viability in PC12 cells", Neurochem Int, 40, pp.361~369 (2002)
7. Holtz WA, "Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics", J Neurochem, 99, pp.54~69 (2006)
8. Kim-Han JS, "Cell Stress Induced by the parkinsonian mimetic, 6-Hydroxydopamine, is concurrent with oxidation of the chaperone, ERp57, and aggresome formation", Antioxid Redox Signal, 9, pp.2255~2264 (2007)
9. Besirli CG, "Cytosine arabinoside rapidly activates Bax-dependent apoptosis and a delayed Bax-independent death pathway in sympathetic neurons", Cell Death Differ, 10, pp.1045~1058 (2003)
10. Singh S, "Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide", Redox Rep, 15, pp.115~122 (2010)
11. Lin Y, "Luteolin, a flavonoid with potential for cancer prevention and therapy", Curr Cancer Drug Targets, 8, pp.634~646 (2008)
12. Lin YP, "Neural cell protective compounds isolated from Phoenix hanceana var. formosana", Phytochemistry, 70, pp.1173~1181 (2009)
13. Donfack JH, "Antihepatotoxic and antioxidant activities of methanol extract and isolated compounds from Ficus chlamydocarpa", Nat Prod Commun, 5, pp.1607~1612 (2010)
14. Zhao G, "Postischemic administration of liposome-encapsulated luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral artery occlusion model", J Nutr Biochem, 22, pp.929~936 (2011)
15. Pavlica S, "Protective effects of flavonoids and two metabolites against oxidative stress in neuronal PC12 cells", Life Sci, 86, pp.79~86 (2010)
16. Wang SQ, "Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells", Bioorg Med Chem Lett, 20, pp.6411~6415 (2010)
17. Xavier CP, "Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells", Cancer Lett, 281, pp.162~170 (2009)
18. Zhang Q, "Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2", M arrest and apoptosis, 2009, pp.23, 797~807
19. Tatton WG, "Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells", J Pharmacol Exp Ther, 301, pp.753~764 (2002)
20. Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J Immunol Methods, 65, pp.55~63 (1983)
21. Andrisano V, "Studies on the photostability and in vitro phototoxicity of Labetalol", Eur J Pharm Sci, 12, pp.495~504 (2001)
22. Oberhammer FA, "Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1", Proc Natl Acad Sci USA, 89, pp.5408~5412 (1992)
23. Fu W, "Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis", Neurobiol Dis, 5, pp.229~243 (1998)
24. Rong P, "Nerve growth factor determines survival and death of PC12 cells by regulation of the bcl-x, bax, and caspase-3 genes", J Neurochem, 72, pp.2294~2300 (1999)
25. Lindenboim L, "Bcl-xS and Bax induce different apoptotic pathways in PC12 cells", Oncogene, 19, pp.1783~1793 (2000)
26. Greene LA, "Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor", Proc Natl Acad Sci U S A, 73, pp.2424~2428 (1976)
27. Kadota T, "Expression of dopamine transporter at the tips of growing neurites of PC12 cells", J Histochem Cytochem, 44, pp.989~996 (1996)
28. Das KP, "Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures", Neurotoxicol Teratol, 26, pp.397~406 (2004)
29. Schulz JB, "Anti-apoptotic gene therapy in Parkinson's disease", J Neural Transm Suppl, 70, pp.467~476 (2006)
30. Camins A, "Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches", Methods Find Exp Clin Pharmacol, 30, pp.43~65 (2008)
31. Jin Z, "Overview of cell death signaling pathways", Cancer Biol Ther, 4, pp.139~163 (2005)
32. Culmsee C, "p53 in neuronal apoptosis", Biochem Biophys Res Commun, 331, pp.761~777 (2005)
33. 최동국, "Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease", Proceedings of the National Academy of Sciences of the United States of America, 104(19), pp.8161~8166, National Academy of Sciences
34. is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells, "J Neurochem", 2008, 2404~2417
35. Nair VD, "Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease", Apoptosis, 11, pp.955~966 (2006)
36. Mandir AS, "A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism", J Neurochem, 83, pp.186~192 (2002)
37. Chipuk JE, "Dissecting p53-dependent apoptosis", Cell Death Differ, 13, pp.1994~1002 (2006)
38. Chandra J, "Triggering and modulation of apoptosis by oxidative stress", Free Radic Biol Med, 29, pp.323~333 (2000)
39. Fleury C, "Mitochondrial reactive oxygen species in cell death signaling", Biochimie, 84, pp.131~141 (2002)

관련 논문AI추천